PALISADE BIO, INC. (PALI) Net income 2016–2025
PALISADE BIO, INC. (PALI) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$16.8MFY2025 · since FY2016: -$21.1M → -$16.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$16.8M | -16.2% |
| FY2024 | -$14.4M | -17.4% |
| FY2023 | -$12.3M | +13.7% |
| FY2022 | -$14.3M | +46.4% |
| FY2021 | -$26.6M | -157.9% |
| FY2020 | -$10.3M | -23.6% |
| FY2019 | -$8.4M | -69.6% |
| FY2018 | -$4.9M | +68.6% |
| FY2017 | -$15.7M | +25.7% |
| FY2016 | -$21.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PALI financial trends
PALI RevenuePALI Net marginPALI Gross profitPALI Gross marginPALI Operating incomePALI Operating marginPALI Operating cash flowPALI Free cash flowPALI Capital expendituresPALI Return on equityPALI Stock buybacksPALI Dividends paidPALI Total assetsPALI Total liabilitiesPALI Shareholders’ equityPALI overview →